4.3 Review

Pre-treatment re-bleeding following aneurysmal subarachnoid hemorrhage: A systematic review of published prediction models with risk of bias and clinical applicability assessment

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Health Care Sciences & Services

CHARMS and PROBAST at your fingertips: a template for data extraction and risk of bias assessment in systematic reviews of predictive models

Borja M. Fernandez-Felix et al.

Summary: CHARMS and PROBAST are standard tools for data extraction and risk of bias assessment in systematic reviews of clinical prediction models. The authors developed an Excel template to simplify and standardize the review process, promoting better reporting of these reviews.

BMC MEDICAL RESEARCH METHODOLOGY (2023)

Article Neuroimaging

Rebleeding following aneurysmal subarachnoid hemorrhage before 'endovascular first' treatment: a retrospective case-control study of published scoring systems

Arosha S. Dissanayake et al.

Summary: In a retrospective analysis of patients with aneurysmal subarachnoid hemorrhage (aSAH) treated with ultra-early intervention, the World Federation of Neurosurgical Societies (WFNS) grade was found to be superior to three published models for predicting re-bleeding.

JOURNAL OF NEUROINTERVENTIONAL SURGERY (2023)

Article Neuroimaging

Cerebral aneurysms: Germany-wide real-world outcome data of endovascular or neurosurgical treatment from 2007 to 2019

Christian Haverkamp et al.

Summary: This study analyzed the clinical outcomes of endovascular treatment (EVT) and neurosurgical clipping for intracranial aneurysms (IAs) in Germany. The results showed that EVT had better functional independence and similar mortality rates compared to clipping.

JOURNAL OF NEUROINTERVENTIONAL SURGERY (2023)

Review Public, Environmental & Occupational Health

Case Fatality Rates of Subarachnoid Hemorrhage Are Decreasing with Substantial between-Country Variation: A Systematic Review of Population-Based Studies between 1980 and 2020

Kasper Mahlamaki et al.

Summary: This systematic review examines the changes in case fatality rate (CFR) of subarachnoid hemorrhage (SAH) over the past 40 years. The results indicate a decline in SAH CFR in most populations, particularly in North America and Oceania. The CFR decline was observed in both women and men. However, limited knowledge exists regarding the time trends of SAH CFR, and high-quality data are scarce.

NEUROEPIDEMIOLOGY (2023)

Article Multidisciplinary Sciences

Racial differences in time to blood pressure control of aneurysmal subarachnoid hemorrhage patients: A single-institution study

Xiaofei Zhou et al.

Summary: This study aimed to assess racial differences in presentation, clinical course, and outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH). The results showed that black patients had higher blood pressure at presentation, longer time to blood pressure control, but shorter hospital length of stay. Further studies are needed to determine the impact of racial differences on aSAH.

PLOS ONE (2023)

Review Clinical Neurology

Relationship between preoperative external ventricular drainage and preoperative rebleeding in aneurysmal subarachnoid hemorrhage: A meta-analysis

Cheng Yang et al.

Summary: This study analyzed the relationship between preoperative external ventricular drainage (preop-EVD) and preoperative rebleeding in aneurysmal subarachnoid hemorrhage. The results showed that preop-EVD does not significantly increase the risk of preoperative rebleeding prior to aneurysm repair. Patients with poorer clinical status on admission and aneurysms larger than 1 cm are more likely to experience preoperative rebleeding.

CLINICAL NEUROLOGY AND NEUROSURGERY (2023)

Article Clinical Neurology

Propensity-adjusted analysis of ultra-early aneurysmal subarachnoid hemorrhage treatment and patient outcomes

Stefan W. W. Koester et al.

Summary: This study compared outcomes for patients with aneurysmal subarachnoid hemorrhage who received ultra-early treatment versus later treatment. The results showed that ultra-early treatment did not lead to better neurologic outcome, fewer cases of delayed cerebral ischemia, or shorter length of hospital stay.

ACTA NEUROCHIRURGICA (2023)

Article Clinical Neurology

ABO blood group in aneurysmal subarachnoid haemorrhage-a pilot study

Oliver Richards et al.

Summary: The study aimed to evaluate the distribution and impact of ABO blood group on the baseline characteristics and clinical outcomes of ASAH patients. The results showed that patients with blood group A had a significantly increased risk of developing delayed cerebral ischaemia.

ACTA NEUROCHIRURGICA (2022)

Article Medicine, General & Internal

Association of Onset-to-Treatment Time With Discharge Destination, Mortality, and Complications Among Patients With Aneurysmal Subarachnoid Hemorrhage

Marie-Jeanne Buscot et al.

Summary: This cohort study aimed to assess the optimal onset-to-treatment time for aneurysmal subarachnoid hemorrhage (SAH) in order to maximize patient outcomes. The study found that surgical treatment performed at approximately 12.5 hours after symptom onset resulted in more favorable outcomes, including discharge home and 12-month survival. These findings provide clarity on the optimal treatment timeline for patients with aneurysmal SAH.

JAMA NETWORK OPEN (2022)

Article Clinical Neurology

Intracranial aneurysms: The era of endovascular intervention in Australia

P. Donnelly et al.

Summary: The overall number of intracranial aneurysm (ICA) treatments in Australia has increased over time, with endovascular procedures becoming more common than surgical clipping. Women are more likely to receive treatment, and the highest frequency of treatment per 100,000 people is observed in the 55-64 age group. Tasmania performs the highest number of treatments per capita compared to other Australian states and territories, according to the Medicare Benefits Schedule (MBS) database.

JOURNAL OF CLINICAL NEUROSCIENCE (2022)

Article Clinical Neurology

Development and Internal Validation of the ARISE Prediction Models for Rebleeding After Aneurysmal Subarachnoid Hemorrhage

Jasper Hans van Lieshout et al.

Summary: This study developed a practical prediction model to estimate the risk of aneurysmal rerupture before aneurysm closure and internally validated the model. The results showed that both the base model and the extended model had good discrimination and could reliably estimate the risk of aneurysmal rerupture.

NEUROSURGERY (2022)

Review Clinical Neurology

Predictive factors for pre-intervention rebleeding in aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis

Ronan J. Doherty et al.

Summary: Rebleeding before intervention in aneurysmal subarachnoid hemorrhage (aSAH) can be caused by various factors, such as increased systolic blood pressure, poorer clinical grades, and higher radiological grades. Awareness of these potential risk factors is crucial for evaluating patients and ensuring timely management.

NEUROSURGICAL REVIEW (2022)

Article Clinical Neurology

Timelines and rebleeds in patients admitted into neurosurgical care for aneurysmal subarachnoid haemorrhage

Angelika Sorteberg et al.

Summary: A retrospective analysis of 544 patients with aneurysmal subarachnoid haemorrhage revealed that the risk of rebleeding is present throughout the entire management timeline, even with ultra-early aneurysm repair. Several modifiable factors were identified to be linked to rebleeding, highlighting the importance of identifying and optimizing these factors within neurosurgical departments.

ACTA NEUROCHIRURGICA (2021)

Article Health Care Sciences & Services

Re-evaluation of the comparative effectiveness of bootstrap-based optimism correction methods in the development of multivariable clinical prediction models

Katsuhiro Iba et al.

Summary: This study compared the effectiveness of Harrell's bias correction, .632, and .632+ estimators, finding that the .632+ estimator performed relatively well under small sample settings, especially when regularized estimation methods are adopted.

BMC MEDICAL RESEARCH METHODOLOGY (2021)

Article Medicine, General & Internal

Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial

Rene Post et al.

Summary: In patients with aneurysmal subarachnoid haemorrhage, ultra-early, short-term treatment with tranexamic acid did not improve clinical outcomes at 6 months, as measured by the modified Rankin Scale.

LANCET (2021)

Article Cardiac & Cardiovascular Systems

Trends of Ruptured and Unruptured Aneurysms Treatment in the United States in Post-ISAT Era: A National Inpatient Sample Analysis

Mohamed M. Salem et al.

Summary: The study found that with each passing year, there is a significant decrease in the relative risk ratio of undergoing treatment for aSAH, while the risk of treatment for unruptured intracranial aneurysms remains stable.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Geriatrics & Gerontology

Rebleeding of Ruptured Intracranial Aneurysm After Admission: A Multidimensional Nomogram Model to Risk Assessment

Qingyuan Liu et al.

Summary: This study identified six independent risk factors related to rebleeding after admission in 577 patients with ruptured intracranial aneurysms. Two predicting models were established, with the CMH model showing the highest predicting accuracy. The validation cohort confirmed the superior discrimination ability of the CMH model compared to other models.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Review Health Care Sciences & Services

Time and predictors of time to treatment for aneurysmal subarachnoid haemorrhage (aSAH): a systematic review

Thuy Phuong Nguyen et al.

Summary: Aneurysmal subarachnoid haemorrhage (aSAH) is a serious form of stroke where rapid access to specialist neurocritical care is crucial for better outcomes. Factors associated with time to treatment in aSAH can be categorized into individual factors (e.g. age, sex) and health system factors (e.g. pre-hospital delay). Understanding and addressing these factors can help reduce treatment delays and improve outcomes for aSAH patients.

INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE (2021)

Article Clinical Neurology

Endovascular aneurysm closure during out of office hours is not related to complications or outcome

Jasper H. van Lieshout et al.

NEURORADIOLOGY (2020)

Article Clinical Neurology

Impact of smoking on course and outcome of aneurysmal subarachnoid hemorrhage

H. Slettebo et al.

ACTA NEUROCHIRURGICA (2020)

Article Medicine, General & Internal

PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration

Karel G. M. Moons et al.

ANNALS OF INTERNAL MEDICINE (2019)

Article Medicine, General & Internal

PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies

Robert F. Wolff et al.

ANNALS OF INTERNAL MEDICINE (2019)

Article Clinical Neurology

Twenty-four-hour emergency intervention versus early intervention in aneurysmal subarachnoid hemorrhage

Joseph R. Linzey et al.

JOURNAL OF NEUROSURGERY (2018)

Article Clinical Neurology

Pre-protection re-haemorrhage following aneurysmal subarachnoid haemorrhage: Where are we now?

Benjamin M. Davies et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2015)

Article Clinical Neurology

Predictors of Treatment Delay in Aneurysmal Subarachnoid Hemorrhage Patients

J. Manuel Sarmiento et al.

JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY (2015)

Article Critical Care Medicine

Aneurysm Treatment <24 Versus 24-72 h After Subarachnoid Hemorrhage

Simone C. Oudshoorn et al.

NEUROCRITICAL CARE (2014)

Article Multidisciplinary Sciences

Risk Factors for Rebleeding of Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis

Chao Tang et al.

PLOS ONE (2014)

Article Clinical Neurology

The role of race in time to treatment after subarachnoid hemorrhage

Sonia V. Eden et al.

NEUROSURGERY (2007)